Related Experiment Video
Updated: Mar 20, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Two Cases of Heavy Chain MGUS
Jan Van Keer1, Björn Meijers2, Michel Delforge3
1Nephrology, Dialysis and Renal Transplantation, University Hospitals Leuven, 3000 Leuven, Belgium.
Heavy chain monoclonal gammopathy, a rare condition, can occur without malignancy. These cases suggest monitoring similar to MGUS, with awareness of potential progression to lymphoma.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Heavy chain diseases are rare B-cell lymphomas characterized by immunoglobulin heavy chains without light chains.
- Monoclonal gammopathies represent clonal proliferation of plasma cells producing a single type of immunoglobulin.
Purpose of the Study:
- To describe two cases of asymptomatic heavy chain monoclonal gammopathy.
- To discuss the implications for diagnosis and management in the absence of overt malignancy.
Main Methods:
- Case report of two patients presenting with asymptomatic monoclonal gammopathy.
- Serum and urine immunofixation to detect paraproteins.
- Workup for multiple myeloma and lymphoma.
Main Results:
- Two patients, a 51-year-old woman with alpha paraprotein and a 46-year-old woman with gamma paraprotein, were identified.
- Neither patient had corresponding monoclonal light chains or evidence of multiple myeloma or lymphoma.
- Both cases represent heavy chain monoclonal gammopathy in the absence of clinically apparent malignancy.
Conclusions:
- Heavy chain monoclonal gammopathy can exist asymptomatically, mimicking Monoclonal Gammopathy of Undetermined Significance (MGUS).
- Management should be similar to MGUS, considering a higher risk of progression to lymphoma than myeloma.
- Further research is needed to establish specific guidelines for "heavy chain MGUS".
More Related Videos
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
10:18From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014